APA (7th ed.) Citation

Y, S., Z, M., J, J., C, L., X, B., J, Y., . . . H, Q. (2025). The N6-methyladenosine writer METTL3 promotes breast cancer progression through YTHDF2-dependent posttranscriptional silencing of GSDMD. Apoptosis : an international journal on programmed cell death, 30(1-2), 226. https://doi.org/10.1007/s10495-024-02037-1

Chicago Style (17th ed.) Citation

Y, Shuai, Ma Z, Ju J, Li C, Bai X, Yue J, Wang X, Yuan P, and Qian H. "The N6-methyladenosine Writer METTL3 Promotes Breast Cancer Progression Through YTHDF2-dependent Posttranscriptional Silencing of GSDMD." Apoptosis : An International Journal on Programmed Cell Death 30, no. 1-2 (2025): 226. https://doi.org/10.1007/s10495-024-02037-1.

MLA (9th ed.) Citation

Y, Shuai, et al. "The N6-methyladenosine Writer METTL3 Promotes Breast Cancer Progression Through YTHDF2-dependent Posttranscriptional Silencing of GSDMD." Apoptosis : An International Journal on Programmed Cell Death, vol. 30, no. 1-2, 2025, p. 226, https://doi.org/10.1007/s10495-024-02037-1.